Alessandra Bisio

1.3k total citations
48 papers, 943 citations indexed

About

Alessandra Bisio is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Alessandra Bisio has authored 48 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Alessandra Bisio's work include Cancer-related Molecular Pathways (19 papers), RNA modifications and cancer (10 papers) and RNA Research and Splicing (8 papers). Alessandra Bisio is often cited by papers focused on Cancer-related Molecular Pathways (19 papers), RNA modifications and cancer (10 papers) and RNA Research and Splicing (8 papers). Alessandra Bisio collaborates with scholars based in Italy, United States and United Kingdom. Alessandra Bisio's co-authors include Alberto Inga, Yari Ciribilli, Paola Monti, Gilberto Fronza, Toma Tebaldi, Sara Zaccara, Paola Menichini, Michael A. Resnick, Veronica De Sanctis and Federica Alessandrini and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Alessandra Bisio

47 papers receiving 933 citations

Peers

Alessandra Bisio

ONCOL

PRM

IMMUN

Sarah E. Golding United States

Sanghyun Lee South Korea

Arifumi Iwamaru Japan

Sandra Mongera Netherlands

Nayoung Jun South Korea

Víctor J. Sánchez‐Arévalo Lobo Spain

Jianhong Zuo China

Ismail Hassan Ismail Canada

Zdeněk Andrysík United States

Shaojie Jiang China

Sarah E. Golding United States

Alessandra Bisio

1.0k ×1.6

489 ×1.2

ONCOL

206 ×0.8

104 ×1.0

PRM

55 ×0.7

IMMUN

Citations per year, relative to Alessandra Bisio Alessandra Bisio (= 1×) peers Sarah E. Golding

Countries citing papers authored by Alessandra Bisio

Since Specialization

Citations

This map shows the geographic impact of Alessandra Bisio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bisio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bisio more than expected).

Fields of papers citing papers by Alessandra Bisio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Bisio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bisio. The network helps show where Alessandra Bisio may publish in the future.

Co-authorship network of co-authors of Alessandra Bisio

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Bisio. A scholar is included among the top collaborators of Alessandra Bisio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Bisio. Alessandra Bisio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciribilli, Yari, S. Brugnara, Carlo Mosci, et al.. (2025). Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanoma. Cell Death Discovery. 12(1). 39–39.

Croci, Stefania, Riccardo Filadi, Alessandra Bisio, et al.. (2024). Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R. Molecular Pharmaceutics. 21(8). 3848–3865. 1 indexed citations

Ferro, Antonella, Michela Campora, A. Caldara, et al.. (2024). Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer. Journal of Clinical Medicine. 13(12). 3611–3611. 8 indexed citations

Ghetti, Sabrina, et al.. (2023). PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability. EMBO Reports. 24(12). e57234–e57234. 10 indexed citations

Forcato, Mattia, Giovanni Bertalot, Mattia Barbareschi, et al.. (2023). ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis. Cell Death and Disease. 14(4). 11 indexed citations

Bolcaen, Julie, et al.. (2023). Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer. Pharmaceuticals. 16(2). 219–219. 6 indexed citations

Zucal, Chiara, Alessandra Bisio, Alessandro Provenzani, et al.. (2021). Limonium duriusculum (de Girard) Kuntze Exhibits Anti-inflammatory Effect Via NF-κB Pathway Modulation. Brazilian Archives of Biology and Technology. 64. 3 indexed citations

Bisio, Alessandra, et al.. (2021). Radiation Resistance: A Matter of Transcription Factors. Frontiers in Oncology. 11. 662840–662840. 69 indexed citations

Monti, Paola, Yari Ciribilli, Giorgia Foggetti, et al.. (2019). P63 modulates the expression of theWDFY2gene which is implicated in cancer regulation and limb development. Bioscience Reports. 39(12). 7 indexed citations

10.

Helm, Alexander, Daniel K. Ebner, Walter Tinganelli, et al.. (2018). Combining Heavy-Ion Therapy with Immunotherapy: An Update on Recent Developments. International Journal of Particle Therapy. 5(1). 84–93. 20 indexed citations

11.

Ebner, Daniel K., Walter Tinganelli, Alexander Helm, et al.. (2017). Generating and grading the abscopal effect: proposal for comprehensive evaluation of combination immunoradiotherapy in mouse models. Translational Cancer Research. 6. 2 indexed citations

12.

Bruno, William, Virginia Andreotti, Alessandra Bisio, et al.. (2017). Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development. PLoS ONE. 12(12). e0189123–e0189123. 1 indexed citations

13.

Ebner, Daniel K., Walter Tinganelli, Alexander Helm, et al.. (2017). The Immunoregulatory Potential of Particle Radiation in Cancer Therapy. Frontiers in Immunology. 8. 99–99. 52 indexed citations

14.

Villela‐Nogueira, Cristiane Alves, Henrique Sérgio Moraes Coelho, Mário Guimarães Pessôa, et al.. (2017). Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics. 72(6). 378–385. 2 indexed citations

15.

Tebaldi, Toma, Sara Zaccara, Federica Alessandrini, et al.. (2015). Whole-genome cartography of p53 response elements ranked on transactivation potential. BMC Genomics. 16(1). 464–464. 52 indexed citations

16.

Leão, Miguel, Clara Pereira, Alessandra Bisio, et al.. (2013). Discovery of a new small-molecule inhibitor of p53–MDM2 interaction using a yeast-based approach. Biochemical Pharmacology. 85(9). 1234–1245. 51 indexed citations

17.

Ozretić, Petar, Alessandra Bisio, Alberto Inga, & Sonja Levanat. (2012). The growing relevance of cap-independent translation initiation in cancer-related genes. Periodicum Biologorum. 114(4). 471–478. 3 indexed citations

18.

Monti, Paola, Chiara Perfumo, Alessandra Bisio, et al.. (2011). Dominant-Negative Features of Mutant TP53 in Germline Carriers Have Limited Impact on Cancer Outcomes. Molecular Cancer Research. 9(3). 271–279. 64 indexed citations

19.

Andreotti, Virginia, Yari Ciribilli, Paola Monti, et al.. (2011). p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System. PLoS ONE. 6(6). e20643–e20643. 37 indexed citations

20.

Bisio, Alessandra, Sabina Nasti, Jennifer Jordan, et al.. (2010). Functional analysis of CDKN2A/p16INK4a 5′-UTR variants predisposing to melanoma. Human Molecular Genetics. 19(8). 1479–1491. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact